Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Zoetis ( (ZTS) ) just unveiled an update.
Zoetis Inc. reported that, effective May 20, 2026, long-serving director Louise M. Parent retired from its board in line with the company’s director retirement policy, ahead of the 2026 Annual Meeting of Shareholders held the same day. At the meeting, which drew 379,034,516 shares representing 90.13% of eligible voting power, shareholders elected twelve directors for one-year terms, effectively maintaining the existing board composition despite Parent’s departure.
Investors also backed, on a non-binding basis, the existing executive compensation program and voted to continue holding say-on-pay advisory votes annually, reinforcing support for Zoetis’s current governance and pay practices. Shareholders ratified KPMG LLP as independent auditor for 2026, but voted down a shareholder proposal to permit action by written consent, signaling preference for the company’s current shareholder rights framework and potentially limiting avenues for activist interventions.
The most recent analyst rating on (ZTS) stock is a Buy with a $112.00 price target. To see the full list of analyst forecasts on Zoetis stock, see the ZTS Stock Forecast page.
Spark’s Take on ZTS Stock
According to Spark, TipRanks’ AI Analyst, ZTS is a Neutral.
The score is anchored by strong underlying profitability and solid cash generation, but is held back by a very weak technical picture (deep downtrend) and near-term business uncertainty highlighted on the earnings call, particularly in U.S. companion animal. Valuation and dividend provide some support, but not enough to overcome the negative momentum.
To see Spark’s full report on ZTS stock, click here.
More about Zoetis
Zoetis Inc. is a global animal health company that develops, manufactures and markets medicines, vaccines and diagnostics for livestock and companion animals. The company focuses on providing veterinary products and services that support the productivity and wellbeing of animals, serving livestock producers, veterinarians and pet owners worldwide.
Average Trading Volume: 5,387,755
Technical Sentiment Signal: Sell
Current Market Cap: $33.42B
See more insights into ZTS stock on TipRanks’ Stock Analysis page.